Lobbying Information
Subject Matters
- Aboriginal Affairs
- Consumer Issues
- Defence
- Education
- Employment and Training
- Environment
- Fisheries
- Forestry
- Health
- Industry
- Infrastructure
- Intellectual Property
- Internal Trade
- International Relations
- International Trade
- Justice and Law Enforcement
- Regional Development
- Science and Technology
- Small Business
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Budget/budget update with respect to the innovative pharmaceutical sector
Policies or Program
- Policies and submissions relating to counterfeiting of innovative pharmaceutical products
- Science and technology policy with respect to advancing Canadian Research & Development interests in the innovative pharmaceutical sector
- Support for the establishment of a National Pharmaceutical Strategy
Regulation
- Food and drug Regulations as it relates to the innovative pharmaceutical sector
- Support for changes to the Patented Medicines (Notice of compliance) Regulations that reflect Canada's international trade commitments
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Aboriginal Affairs and Northern Development Canada
-
Agriculture and Agri-Food Canada (AAFC)
-
Atlantic Canada Opportunities Agency (ACOA)
-
Atomic Energy Control Board (AECB)
-
Canadian International Development Agency (CIDA)
-
Canadian International Trade Tribunal (CITT)
-
Citizenship and Immigration Canada
-
Environment Canada
-
Federal Office of Regional Development – Quebec (FORD[Q])
-
Finance Canada (FIN)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
Human Resources Development Canada (HRDC)
-
Industry Canada
-
Justice Canada (JC)
-
Members of the House of Commons
-
National Defence (DND)
-
National Research Council (NRC)
-
Natural Resources Canada (NRCan)
-
Natural Sciences and Engineering Research Council (NSERC)
-
Office of the Information and Privacy Commissioner (OIPC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Works and Government Services Canada
-
Revenue Canada (RC)
-
Science & Technology Innovation Council of Canada
-
Senate of Canada
-
Solicitor General Canada (SGC)
-
Transport Canada (TC)
-
Treasury Board Of Canada Secretariat (TBS)
-
Veterans Affairs Canada (VAC)
-
Western Economic Diversification Canada (WD)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
1220-55 Metcalfe St.
Ottawa, ON K1P 6L5
Canada
Telephone number:
613-236-0455
Fax number:
613-236-7919
Client representative
Normand Laberge, Vice President, Federal Affairs and Federal, Provincial &Territorial Relations
Parent Company Information
Canada's Research -Based Pharmaceutical Companies Rx&D is not a subsidiary of any other parent companies.
Coalition Members Information
Canada's Research -Based Pharmaceutical Companies Rx&D is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Canada's Research -Based Pharmaceutical Companies Rx&D are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Canada's Research -Based Pharmaceutical Companies Rx&D does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
ANDRE ALBINATI
|
Public offices held
Business address:
Suite 200, 46 Elgin Street
OTTAWA, ON K1P 5K6
Canada
Telephone number:
613-563-4455
Fax number:
613-236-6173
Consultant Firm and Address
Firm:
Earnscliffe Strategy Group
Address:
Suite 200, 46 Elgin Street
OTTAWA, ON K1P 5K6
Canada
Telephone number:
613-563-4455
Fax number:
613-236-6173